Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 51.19
-0.06 (-0.12%)
May 9, 2025, 2:45 PM CST
Cathay Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | 520.65 | 488.96 | 366.52 | 553.27 | 594.72 | 457.67 | Upgrade
|
| Depreciation & Amortization | 315.92 | 315.92 | 285.72 | 265.12 | 168.54 | 118.32 | Upgrade
|
| Other Amortization | 9.54 | 9.54 | 3.88 | 4.68 | 3.68 | 2.27 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.4 | -0.4 | 0.01 | -0.05 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.04 | 0.04 | 4.93 | 36.22 | 10.69 | 12.93 | Upgrade
|
| Loss (Gain) From Sale of Investments | 8.95 | 8.95 | 7.82 | 3.71 | -16.3 | -27.97 | Upgrade
|
| Provision & Write-off of Bad Debts | 3.34 | 3.34 | -6.27 | - | - | - | Upgrade
|
| Other Operating Activities | -86.88 | 72.6 | 76.88 | -3.57 | 25.36 | 24.35 | Upgrade
|
| Change in Accounts Receivable | -246.25 | -246.25 | -320.06 | 24.8 | -224.95 | -25.54 | Upgrade
|
| Change in Inventory | 198.51 | 198.51 | 78.3 | -418.06 | -282.62 | -90.45 | Upgrade
|
| Change in Accounts Payable | 22.48 | 22.48 | 133.66 | 355.46 | 310.02 | 33.28 | Upgrade
|
| Change in Other Net Operating Assets | -1.26 | -1.26 | 8.65 | 18.18 | 6.47 | 5.35 | Upgrade
|
| Operating Cash Flow | 693.14 | 820.93 | 569.45 | 803.67 | 578.69 | 514.96 | Upgrade
|
| Operating Cash Flow Growth | -1.75% | 44.16% | -29.14% | 38.88% | 12.37% | 43.20% | Upgrade
|
| Capital Expenditures | -659.81 | -843.31 | -1,570 | -4,198 | -1,459 | -763.11 | Upgrade
|
| Sale of Property, Plant & Equipment | 20.25 | 20.25 | 142.01 | 0.14 | - | - | Upgrade
|
| Investment in Securities | -25.5 | - | -101.04 | - | 1,320 | -470 | Upgrade
|
| Other Investing Activities | - | - | -30 | - | 28.42 | 35.88 | Upgrade
|
| Investing Cash Flow | -665.06 | -823.06 | -1,559 | -4,198 | -110.76 | -1,197 | Upgrade
|
| Long-Term Debt Issued | - | 1,889 | 937.02 | 1,126 | 798.08 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -300.24 | Upgrade
|
| Long-Term Debt Repaid | - | -1,570 | -289.77 | -740 | -55 | - | Upgrade
|
| Total Debt Repaid | -1,513 | -1,570 | -289.77 | -740 | -55 | -300.24 | Upgrade
|
| Net Debt Issued (Repaid) | 174.77 | 319.26 | 647.25 | 386.47 | 743.08 | -300.24 | Upgrade
|
| Issuance of Common Stock | 5,915 | - | 4.17 | 4.52 | - | 6,661 | Upgrade
|
| Repurchase of Common Stock | -28.93 | -28.93 | -31.52 | -94.67 | - | - | Upgrade
|
| Common Dividends Paid | -143.08 | -140.83 | -137.75 | -206.85 | -339.63 | -3.87 | Upgrade
|
| Dividends Paid | -143.08 | -140.83 | -137.75 | -206.85 | -339.63 | -3.87 | Upgrade
|
| Other Financing Activities | -131.05 | - | -744.31 | 314.41 | 2,584 | -293.06 | Upgrade
|
| Financing Cash Flow | 5,786 | 149.49 | -262.16 | 403.88 | 2,987 | 6,063 | Upgrade
|
| Foreign Exchange Rate Adjustments | 26.12 | 24.82 | 40.22 | 59.98 | -9.19 | -2.83 | Upgrade
|
| Net Cash Flow | 5,841 | 172.19 | -1,211 | -2,931 | 3,446 | 5,378 | Upgrade
|
| Free Cash Flow | 33.33 | -22.38 | -1,000 | -3,395 | -880.49 | -248.15 | Upgrade
|
| Free Cash Flow Margin | 1.09% | -0.76% | -47.32% | -139.06% | -37.25% | -16.57% | Upgrade
|
| Free Cash Flow Per Share | 0.06 | -0.04 | -1.72 | -5.83 | -1.51 | -0.46 | Upgrade
|
| Cash Income Tax Paid | 261.01 | 229.15 | 90.88 | -281.56 | -12.97 | 36 | Upgrade
|
| Levered Free Cash Flow | -225.95 | -418.14 | -567.98 | -3,302 | -1,301 | -673.57 | Upgrade
|
| Unlevered Free Cash Flow | -210.64 | -400.99 | -547.87 | -3,290 | -1,290 | -671.16 | Upgrade
|
| Change in Net Working Capital | 129.14 | 105.03 | -622.24 | -368.28 | 321.72 | 308.6 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.